New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 3, 2013
16:20 EDTARAYAccuray cites reasons for Q2 shortfall
The second fiscal quarterly results reflect a shortfall relative to expectations, which is attributable to challenges faced in two primary areas of the business: (1) manufacturing and supply related issues, which delayed contribution from new products launched at the 2012 Annual Meeting of the American Society for Radiation Oncology, ASTRO, and (2) commercial focus and salesforce transitional issues.
News For ARAY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 30, 2015
19:01 EDTARAYOn The Fly: After Hours Movers
UP AFTER EARNINGS: Ellie Mae (ELLI), up 10%... Ocwen Financial (OCN), up 9%... athenahealth (ATHN), up 8.5%... Expedia (EXPE), up 4.5%... Skyworks Solutions (SWKS), up 3.7%... Eastman Chemical (EMN), up 2.4%... Nektar Therapeutics (NKTR), up 1.4%... FireEye (FEYE), up 2%. ALSO HIGHER: Monsanto (MON), up 3.6% following a Bloomberg report that the company approached Syngenta (SYT) about a takeover... Altera (ALTR), up 4.4% following a Reuters report that Intel (INTC) has a standstill pact set to end in June. DOWN AFTER EARNINGS: LinkedIn (LNKD), down 21.3%... Hutchinson Technology (HTCH), down 15.3%... Insulet (PODD), down 13.9%... Accuray (ARAY), down 14%... Constant Contact (CTCT), down 9.9%... Trimble Navigation (TRMB), down 6.6%... First Solar (FSLR), down 4.4%... JDS Uniphase (JDSU), down 3%... BioMarin (BMRN), down 1.8%... Visa (V), down 1.6%.
16:16 EDTARAYAccuray signs development agreement with MIM Software
Accuray Incorporated announced that it has signed an agreement with MIM Software Inc. to further develop adaptive therapy software for the TomoTherapy and CyberKnife product portfolios. The new software solution will leverage both Accuray and MIM technology. This is Accuray's second collaboration with MIM; the previous partnership led to the development of the first iPad-based treatment plan review capability, PlanTouch.
16:15 EDTARAYAccuray reports Q3 EPS (4c), consensus (6c)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use